The Belgium-based Solvay published financial achievements of Jan-Mar 2012

(chemmonitor) -- The Brussels-headquartered Belgium company Solvay S.A. unveiled its financial results of January-March 2012.

The company's REBITDA dropped by about 9% year on year, in Q1 2012, and demonstrated a 47% hike, if compared to October-December 2011.

Solvay?s net sales from January through March reached about EUR 3.2 million. The figure rose by 8.1% year on year and by around 3%, as opposed to Q1 of the last year.

The Belgium chemical company showed a snug increase in its business through Q1, 2012.

MRC

СИНГАПУР (ICIS) -- В Китае импорт полиэтилена (ПЭ) и полипропилена (ПП) в апреле, по оценкам участников рынка, снизился на 173,300 тонн или на 16,8% по сравнению с показателями марта. В апреле импорт ПЭ и ПП в Китай составил 520,000т и 340,000 тонн соответственно, добавил источник.

По данным китайской таможни, в марте было импортировано 626,100 тонн полиэтилена и 407,200 тонн полипропилена. Китайская таможня не сообщила объемы импорта в апреле, так как данные за каждый месяц обычно доступны лишь после 20-го числа следующего месяца.


Участники рынка рассказали, что покупательский интерес был невысоким, так как цены большинства импортного материала превышали внутренние цены в Китае. Местные трейдеры отмечают, что участники рынка сохраняют пессимистичные прогнозы. Трейдеры, в основном, продают запасы и придерживаются арбитражных сделок.

Перевод и редакция новости: Маркет Репорт.

mrcplast.ru

(cokecce) -- Coca-Cola Enterprises and ECO Plastics joint venture set to deliver step change in GB plastics recycling ECO Plastics' plant becomes world's largest plastics processing facility.

Coca-Cola Enterprises Ltd (CCE) and ECO Plastics announce the official opening of their groundbreaking joint venture, Continuum Recycling.

Completed on time and on budget, the GBR15 million facility is a first for Great Britain, and brings the recycling process full circle, with used plastic packaging sorted and reprocessed domestically, before returning to GB shelves as part of another bottle.

Simon Baldry, Managing Director of Coca-Cola Enterprises, said: "Our investment in Continuum Recycling shows that we are serious about setting the industry standard for sustainable packaging. Today's opening of this 15mln state of the-art facility will transform recycling in this country and ensure that we achieve our ambition of incorporating 25% recycled PET in our plastic bottles. This is a first for the industry and an important milestone in our ongoing efforts to build a low-carbon, zero waste business here in Great Britain."
MRC

(plasteurope) -- Europe's leading supplier of rigid plastic packaging RPC Group presented a very positive picture of performance in its recent pre-close trading statement for the financial year to 31 March 2012.

Turnover is expected to be well ahead of last year due to the inclusion of the Superfos business, acquired in February 2011 and higher like-for-like revenues. Volumes have been similar to the previous year, despite the continuing trend towards light-weighting, but the sales mix improved significantly towards higher added-value products, such as coffee capsules, long shelf-life packaging and personal care and pharmaceutical products.

Margins were impacted in Q4 last year as polymer prices rose by up to 20%, increases that RPC only plans to pass on in the coming quarters. Operating profit for the year, excluding exceptional items, will be well ahead of the previous 12 months, RPC said, reflecting the improved revenue position as well as expectations based on the group's half-year performance.

This will be in line with management expectations that will surely have been based on the half-year performance that saw overall revenue increase by over 50% and operating profits doubled. RPC says there was good cash flow development in the fourth quarter and the financial position remains robust, with significant headroom under the groups debt facilities.
MRC

(merckgroup) -- The Merck Groups first-quarter 2012 total revenues rose 3.2% to EUR 2,645 million compared to EUR 2,564 million in the first quarter of 2011.

Sales for the Group increased 3.5% to EUR2,564 million in first quarter compared to EUR2,478 million in the year-ago quarter.

This performance reflected organic sales growth of 1.2%, a 1.7% positive benefit from changes in foreign exchange rates and a 0.6% boost from acquisitions and divestments.

The Groups organic sales growth was entirely driven by the Merck Serono and Merck Millipore divisions during the quarter.

The Merck Millipore life science division?s first-quarter 2012 sales rose 7.3% year on year to EUR653m, driven by solid results from its lab solutions and process solutions business units.

Pharmaceutical division Merck Seronos first-quarter sales increased 5.4% to EUR1.42bn year on year, while the groups consumer health division reported sales of EUR108m, a 7.4% decline compared to EUR116m in the first quarter of 2011.

Looking at the year as a whole, Merck expects total revenues of around EUR10.5bn and earnings before interest, tax, depreciation and amortisation (EBITDA) before one-time items of EUR 2.8bn-2.9bn.
MRC